(Q42203839)

English

Continuous infusion of ceftazidime in critically ill patients undergoing continuous venovenous haemodiafiltration: pharmacokinetic evaluation and dose recommendation

scientific article published on February 2006

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

18 October 2017

Continuous infusion of ceftazidime in critically ill patients undergoing continuous venovenous haemodiafiltration: pharmacokinetic evaluation and dose recommendation (English)

1 reference

Europe PubMed Central

PMC publication ID

18 October 2017

1 reference

based on heuristic

inferred from title

pharmacokinetics

1 reference

based on heuristic

inferred from title

hemodiafiltration

1 reference

based on heuristic

inferred from title

author name string

Christophe Mariat

1

1 reference

Europe PubMed Central

PMC publication ID

18 October 2017

Christophe Venet

2

1 reference

Europe PubMed Central

PMC publication ID

18 October 2017

François Jehl

3

1 reference

Europe PubMed Central

PMC publication ID

18 October 2017

Sandrine Mwewa

4

1 reference

Europe PubMed Central

PMC publication ID

18 October 2017

Vesna Lazarevic

5

1 reference

Europe PubMed Central

PMC publication ID

18 October 2017

Eric Diconne

6

1 reference

Europe PubMed Central

PMC publication ID

18 October 2017

Nathalie Fonsale

7

1 reference

Europe PubMed Central

PMC publication ID

18 October 2017

Anne Carricajo

8

1 reference

Europe PubMed Central

PMC publication ID

18 October 2017

Stéphane Guyomarc'h

9

1 reference

Europe PubMed Central

PMC publication ID

18 October 2017

Régine Vermesch

10

1 reference

Europe PubMed Central

PMC publication ID

18 October 2017

Gérald Aubert

11

1 reference

Europe PubMed Central

PMC publication ID

18 October 2017

Roselyne Bidault

12

1 reference

Europe PubMed Central

PMC publication ID

18 October 2017

Jean-Claude Bertrand

13

1 reference

Europe PubMed Central

PMC publication ID

18 October 2017

Fabrice Zeni

14

1 reference

Europe PubMed Central

PMC publication ID

18 October 2017

publication date

1 February 2006

1 reference

Europe PubMed Central

PMC publication ID

18 October 2017

1 reference

Europe PubMed Central

PMC publication ID

18 October 2017

10

1 reference

Europe PubMed Central

PMC publication ID

18 October 2017

1

1 reference

Europe PubMed Central

PMC publication ID

18 October 2017

R26

1 reference

Europe PubMed Central

PMC publication ID

18 October 2017

Continuous infusion of ceftazidime in the empiric treatment of febrile neutropenic children with cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1550796

26 October 2017

Continuous infusion of ceftazidime for patients with breast cancer and multiple myeloma receiving high-dose chemotherapy and peripheral blood stem cell transplantation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1550796

26 October 2017

Pharmacokinetics of cefepime during continuous renal replacement therapy in critically ill patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1550796

26 October 2017

Does the dose matter?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1550796

26 October 2017

Pharmacokinetic-pharmacodynamic evaluation of ceftazidime continuous infusion vs intermittent bolus injection in septicaemic melioidosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1550796

26 October 2017

Determinants of ceftazidime clearance by continuous venovenous hemofiltration and continuous venovenous hemodialysis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1550796

26 October 2017

Individualized drug dosage in patients treated with continuous hemofiltration.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1550796

26 October 2017

Pharmacokinetic principles during continuous renal replacement therapy: drugs and dosage

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1550796

26 October 2017

Is continuous infusion of beta-lactam antibiotics worthwhile?--efficacy and pharmacokinetic considerations

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1550796

26 October 2017

Continuous infusion versus intermittent administration of ceftazidime in critically ill patients with suspected gram-negative infections

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1550796

26 October 2017

Killing of Pseudomonas aeruginosa during continuous and intermittent infusion of ceftazidime in an in vitro pharmacokinetic model

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1550796

26 October 2017

Pharmacokinetics of ceftazidime in normal and uremic subjects

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1550796

26 October 2017

Continuous infusion of beta-lactam antibiotics

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1550796

26 October 2017

Pharmacokinetics of antimicrobial agents in anuric patients during continuous venovenous haemofiltration.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1550796

29 May 2018

Pharmacokinetics of antibiotics in critically ill patients.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1550796

29 May 2018

Pharmacokinetics of ceftazidime in normal subjects

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1550796

17 August 2018

Determination of ceftazidime and cefepime in plasma and dialysate-ultrafiltrate from patients undergoing continuous veno-venous hemodiafiltration by HPLC.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1550796

17 August 2018

Cefepime and continuous renal replacement therapy (CRRT): in vitro permeability of two CRRT membranes and pharmacokinetics in four critically ill patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1550796

17 August 2018

Plasma and lung concentrations of ceftazidime administered in continuous infusion to critically ill patients with severe nosocomial pneumonia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1550796

17 August 2018

Clearance of ceftazidime during continuous venovenous haemofiltration in critically ill patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1550796

17 August 2018

Pharmacokinetics of ceftazidime in serum and peritoneal exudate during continuous versus intermittent administration to patients with severe intra-abdominal infections

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1550796

17 August 2018

Continuous versus intermittent administration of ceftazidime in intensive care unit patients with nosocomial pneumonia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1550796

17 August 2018

Drug clearance by continuous haemodiafiltration. Analysis of sieving coefficients and mass transfer coefficients of diffusion.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1550796

17 August 2018

Pharmacokinetics of ceftazidime in adult cystic fibrosis patients during continuous infusion and ambulatory treatment at home.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1550796

17 August 2018

Stability of reconstituted solutions of ceftazidime for injections: an HPLC and CE approach

1 reference

https://pubmed.ncbi.nlm.nih.gov/16507147

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intermittent and continuous ceftazidime infusion for critically ill trauma patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/16507147

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of hemodialysis on ceftazidime pharmacokinetics

1 reference

https://pubmed.ncbi.nlm.nih.gov/16507147

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dosage adjustment for ceftazidime in patients with impaired renal function

1 reference

https://pubmed.ncbi.nlm.nih.gov/16507147

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The pharmacokinetics of ceftazidime in patients with impaired renal function and concurrent frusemide therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/16507147

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High-performance liquid chromatography of antibiotics

1 reference

https://pubmed.ncbi.nlm.nih.gov/16507147

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The pharmacokinetics of ceftazidime during hemodiafiltration in critically ill patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/16507147

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

1 reference

Europe PubMed Central

PMC publication ID

18 October 2017

Dimensions Publication ID

0 references

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

18 October 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

18 October 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42203839&oldid=2205117581"